<DOC>
	<DOCNO>NCT02868775</DOCNO>
	<brief_summary>This prospective pilot study , recruitment goal 60 patient . Patients female , age 18 , diagnosis IC/BPS base clinical criterion O'Leary Sant ICPI ICSI score undergoing cystoscopy , hydrodistention bladder biopsy include . The bladder biopsy evaluate TLR4 expression , send histological assessment mast cell count . Additionally , data collect baseline , day surgery , day 7 , day 14 day 28 . Data include validate questionnaire , low urinary tract symptom , record pain medication use .</brief_summary>
	<brief_title>A Study Determine Role Toll-like Receptor-4 Expression Patients With Interstitial Cystitis/Bladder Pain Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<criteria>1 . Patients must candidate cystoscopy , hydrodistention bladder biopsy . 2 . Participant must subjective complaint 1. urinary urgency , relieve voiding , OR 2. urinary frequency ; â‰¥ 8 void per day , OR 3. pelvic pain , pressure , discomfort 2 . Gender subject : Subjects study female . Pregnant woman breastfeed woman exclude due unknown risk study medication pregnancy fetus nursing infant . 3 . Age subject : Age subject range 18 90 year . 4 . Racial ethnic origin : There enrollment restriction base upon race ethnic origin . The racial ethnic distribution subject entirely base population patient study site . 5 . Other inclusion criterion : 1 . Participant must give write informed consent participate study 2 . Participant must able make decision 3 . Participant must UTI within 7 day prior start study 4 . Female participant positive pregnancy test To participate study subject must meet following criterion : 1 . Participant currently pregnant breastfeed 2 . Participant positive urinary pregnancy test time screen 3 . Participant currently antibiotic therapy last 7 day prior start study 4 . Participant currently another trial 5 . Participant active S3 nerve stimulator implant PTNS 6 . Participant intravesical botulinum toxin injection 6 month prior start study 7 . Participant grade III IV pelvic organ prolapse 8 . Participant history bladder cancer 9 . Participant neurological disease include , limited , multiple sclerosis , Parkinson 's disease , Alzheimer 's disease , spinal cord injury , brain injury , stroke dementia 10 . Participant urinary frequency le 8 times/day 11 . Participant bladder lower ureteral calculus 12 . Participant active genital herpes 13 . Participant urethral diverticulum 14 . Participant chemical cystitis 15 . Participant radiation tuberculosis cystitis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>